Annette is President of Oestreicher Medical Communications, Inc. which she founded in 1992. She also currently serves on the board of Institutional Review Boards (IRBs), Weill Cornell-New York Presbyterian Hospitals (appointed to three IRBs – Cancer 1, General 2, and Executive). Oestreicher Medical Communications provides editing and re-writes for grant submissions, journal manuscripts, and IRB applications. They develop, design, and
Archives: Our Staffs
Our Staff Description
Barbara Hearst
Barbara W. Hearst is a native of Charlotte, North Carolina, and spent most of her life living in New York City and the Hamptons. She currently resides in Charleston, SC. Barbara is a world traveler, painter and a former Board member of TGF, and served on both the Board and Executive Committee for the Institute for Cancer Prevention, as well
Sarah H. Van Tassel, MD
Sarah H. Van Tassel, M.D. is Director of the Glaucoma Service and Glaucoma Fellowship at Weill Cornell Medicine Ophthalmology. Dr. Van Tassel specializes in glaucoma evaluation and treatment, including medical management, laser, and surgical procedures. She also performs cataract surgery and is up-to-date on the latest advances in microinvasive glaucoma surgery (MIGS). A native of Missouri, Dr. Van Tassel completed
David Solá-Del Valle MD
Dr. David Solá-Del Valle (known as Dr. Solá) is a glaucoma and cataract specialist. He became Chief Medical Officer at Chittick Eye Care and Associate Professor at the Carle Illinois College of Medicine in Champaign, IL in February 2024. He was assistant professor at Harvard Medical School until December 2023, where he taught residents, fellows, and medical students in addition
Joseph F. Panarelli, MD
Joseph F. Panarelli, MD is a board-certified ophthalmologist and director of the Glaucoma division at NYU-Langone. He specializes in the treatment of glaucoma in both adult and pediatric patients. Dr. Panarelli’s research interests stem from his passion for innovative surgical approaches and primarily include development of surgical devices and techniques. He is also actively involved in graduate medical education as
John Berdahl, MD
Practicing in Sioux Falls, SD is our board-certified ophthalmologist, John Berdahl, MD. He is widely regarded as one of the leading international cataract surgeons. He is one of the very few surgeons in the United States who is also fellowship trained in cornea, glaucoma, and refractive surgery. Dr. Berdahl has already performed more than 25,000 eye surgeries around the globe.
Aakriti Garg Shukla, MD
Dr. Shukla is the Leonard A. Lauder Assistant Professor of Ophthalmology at Columbia University Medical Center. She received her medical degree at Columbia University College of Physicians & Surgeons, where she completed her ophthalmology residency and served as Chief Resident. She pursued further glaucoma subspecialty training at the Wilmer Eye Institute at Johns Hopkins University in Baltimore, MD. She was
Thomas V. Johnson III, MD, PhD
Dr. Johnson is a glaucoma specialist and a neuroscientist at the Johns Hopkins Wilmer Eye Institute. In addition to caring for patients with glaucoma, he leads a clinical research program that is investigating the use of remote eye pressuring monitoring to better understand intraocular pressure fluctuations in patients with glaucoma. In addition, he runs a translational research laboratory aimed and
Donald J. Zack, MD, PhD
Donald J. Zack, M.D., Ph.D., is the Guerrieri Professor of Genetic Engineering and Molecular Ophthalmology and co-director of the Center for Stem Cells and Ocular Regenerative Medicine (STORM) at the Wilmer Eye Institute. He is also a professor in the departments of Molecular Biology and Genetics, Neuroscience, and the Institute of Genetic Medicine. His lab studies the control of gene
Alon Harris, MS, PhD, FARVO
Professor Alon Harris is an internationally recognized expert and leader in the field of ocular blood flow and glaucoma. Dr. Harris’ academic specialties include novel approaches to glaucoma risk management, developing monitoring techniques for ocular hemodynamics and metabolism, mathematical modeling and artificial intelligence analysis of clinical and physiological biomarkers, investigating glaucoma theraputics, generic medications, and population-based studies. Professor Harris has